Treatment for UCDs, or any IEM, should be done in consultation with an appropriate genetics/metabolic expert. For neonates with hyperammonemia, the immediate treatment goal is a rapid lowering of ammonia and reducing dietary protein intake. Hemodialysis is very effective at reducing plasma ammonia and should immediately be initiated if elevated hyperammonemia is observed. Ammonia scavenger medications such as Ammonul IV are also useful. Ammonul IV acts by removing glycine and glutamate from plasma thereby their reducing contribution to ammonia formation.

N-carbamylglutamate (Carbaglu) is an analog of N-acetylglutamate, and small clinical trials have found it to improve ureagenesis in NAGS deficiency and late-onset CPS1 deficiency